Global Tier-1 YFORE Introduces Mass-Produced Anti-Pinch Sensors
SUWANEE, Ga., Aug. 31, 2026 /PRNewswire/ -- Global Tier-1 supplier YFORE Technology officially commissioned its Suwanee, Georgia facility, showcasing its market-validated Anti-Pinch Sensor solutions. Leveraging near-shore manufacturing, YFORE...
Chula Researchers Develop Synthetic Boar Scent Mimicking Natural Pheromones to Reduce Disease Outbreak Risks in Pig Farms
BANGKOK, Aug. 31, 2026 /PRNewswire/ -- Researchers from Chulalongkorn University 's Faculty of Veterinary Science have developed synthetic boar scent mimicking natural pheromones , providing a safer way to stimulate reproduction while reducing the...
Rewardz Launches VYBE to Bring Enterprise-Grade Employee Perks to Singapore SMEs
SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- To address the growing need for competitive talent retention among small and medium-sized enterprises (SMEs), Rewardz, a leading digital rewards and loyalty solutions provider, today announced the launch of...
YFORE Unveils Multi-Scenario UWB Radar Sensing for Next-Gen Vehicles
SUWANEE, Ga., Aug. 31, 2026 /PRNewswire/ -- Global Tier-1 automotive supplier YFORE Technology showcased its advanced Ultra-Wideband (UWB) radar sensing portfolio and expanded multi-scenario applications at its Suwanee, Georgia facility. Powered by...
Dowinx Reframes Everyday Seating Around the Way People Really Live
The QL-66B6 Executive Office Chair brings adaptive comfort to hybrid spaces for work, gaming and relaxation HONG KONG and LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- As the consumer technology industry looks toward IFA 2026 and the future of...
AU10TIX and NEO Partner to Bring Real-Time Identity Verification to High-Volume Venues
Partnership helps gaming, wagering, hospitality, and travel operators automate identity checks, reduce manual review, and accelerate compliant self-service experiences MELBOURNE, Australia, Aug. 31, 2026 /PRNewswire/ -- AU10TIX, a global identity...
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for autologous...
Amai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage Products
Third regulatory approval in less than six months enables food and beverage manufacturers to commercialize products sweetened with sweelin® in Israel. REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ -- Amai Proteins announces that the Israeli Ministry...